Introduction
============

External ventricular drainage (EVD) is widely used in current neurosurgical practice. EVD is indispensable for patients with acute increase of intracranial pressure, intraventricular hemorrhage, and obstructive hydrocephalus. Although it has potential therapeutic effects, a high risk of catheter-related cerebrospinal fluid infection (CFI) still remains unsolved \[[@B1]\]. Apart from leading to a poor outcome, the infection also contributes to increased length of stay in the ICU and hospital and to higher total hospital costs \[[@B2],[@B3]\].

Prophylactic systemic antibiotics (PSA) are routinely administered for patients with EVD in many institutions. However, PSA may not significantly lower the incidence of ventriculitis \[[@B4]\]. The antimicrobial-impregnated catheter has emerged as an alternative strategy. Currently, catheters impregnated with clindamycin/rifampin (C/R), minocycline/rifampin (M/R), and silver are commercially available \[[@B5]\]. Most studies showed benefits of antimicrobial-impregnated EVD catheters in preventing infections \[[@B3],[@B6]-[@B10]\]. However, some studies did not demonstrate positive conclusions \[[@B11]-[@B13]\]. Gram-positive organisms are predominant in microbiological cultures of cerebrospinal fluid (CSF) samples. Due to the selective pressure exerted by pervasive use of prophylactic antibiotics, an increasing rate of Gram-negative infections has been reported \[[@B1],[@B14],[@B15]\]. The protective effects of antimicrobial-impregnated catheters against Gram-positive or Gram-negative infections have not been clarified. In light of those pending issues, we performed this systematic review and meta-analysis, aiming to evaluate the efficacy of antimicrobial-impregnated EVD catheters.

Methods
=======

Search strategy
---------------

Our meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) statement \[[@B16]\] (see Additional file [1](#S1){ref-type="supplementary-material"}). We systematically searched Medline (Ovid), Embase, and the Cochrane Library until October 2012, with language restricted to English, and identified all prospective studies related to the use of antimicrobial-impregnated EVD catheters. Our search strategy included terms for antimicrobial catheter (antibiotic-impregnated/coated catheter that includes minocycline/rifampin catheters and clindamycin/rifampin catheters, and silver-impregnated/coated catheter), procedures (external ventricular drainage, ventriculostomy, and shunt), and study design (randomized controlled trials, prospective studies). Furthermore, we manually searched the references of identified papers to find additional eligible studies.

Selection criteria
------------------

Studies were included into the meta-analysis if they: were randomized controlled trials (RCTs) or nonrandomized prospective studies (NPSs) of patients with antimicrobial-impregnated catheters; compared the antimicrobial catheter (treatment arm) with the standard catheter (control arm) in the prevention of catheter-related infections in EVD (we eased the criteria for the control arm and allowed the use of well-matched historical controls); reported original data; and reported a risk estimate (that is, odds ratio (OR), relative risk, or hazard ratio (HR)) for the utilization of antimicrobial-impregnated catheters to subsequent rate of catheter-related infections. We referred to the Centers for Disease Control/National Healthcare Safety Network definition of ventriculitis to identify the infectious outcome. According to the criteria, clinical manifestations are emphasized besides laboratory tests \[[@B17]\]. However, most studies had no defined requirements for clinical manifestations. We therefore modified the aforementioned criteria and viewed CFI as the primary outcome, defined as positive CSF culture or staining, or a significant increase of CSF white cell count, with or without clinical manifestations \[[@B17]\]. The rate of time-dependent CFI and catheter bacterial colonization were explored as secondary outcomes. Catheter bacterial colonization was defined as positive culture of explanted catheters *in vitro*. For multiple reports on the same study, the one with complete information was selected for meta-analysis.

Data extraction and quality assessment
--------------------------------------

Two assessors (XW and YD) independently reviewed the full manuscripts of eligible studies. Data were extracted in standardized data-collection forms. The extracted information included the following items: first author\'s name; year of publication; sample size; population; gender; treatment arms; usage of PSA; duration of catheter placement; and catheter-related infection outcomes (infection rate, organism analyses). Any disagreement was resolved by discussion or by consulting a senior scholar (C-GH). Selected RCTs were critically appraised using the Jadad scale (randomization, 2 points; blinding, 2 points; and attrition information, 1 point) \[[@B18]\]. The Newcastle-Ottawa scale was used to evaluate the methodological quality of prospective cohort studies \[[@B19]\]. The quality of a study was judged by the selection of the study groups, the comparability of the groups, and the ascertainment of the outcome.

Statistical analysis
--------------------

Review Manager 5.1.7 (Cochrane Collaboration, Copenhagen, Denmark) was used to perform the meta-analysis. At event rates \<1%, Peto\'s OR is suggested to be the least biased and most powerful method \[[@B20]\]. However, Peto\'s OR is less appropriate when the event rates are \>5%, the treatment effects are significant, and the number of treated and control participants is imbalanced \[[@B20]\]. We therefore used different statistical methods. Besides calculating the Peto OR with a fixed-effect model, we calculated the OR with the Mantel-Haenszel method and the random-effects model \[[@B21],[@B22]\]. When the event rates were \<1%, the treatment effects were small to moderate, and the number in each group was balanced. The Peto OR was thus chosen as the primary statistical method. Otherwise, the OR was used instead.

The comparison of different meta-analytic methods was included into the sensitivity analyses. Additionally, sensitivity analysis was conducted by excluding the individual studies one by one.

Considering the infection events as time-dependent data, the HR was employed for analysis \[[@B23]\]. If available, HRs and associated variances were extracted directly. Otherwise they were estimated indirectly from other summary statistics (95% confidence intervals (CIs), *P*values, total number of events) or from data from published Kaplan-Meier curves \[[@B23]\]. The Kaplan-Meier curve was read with the Engauge Digitizer version 2.15 free software \[[@B24]\]. The log HR and its standard error were calculated and further pooled by Review Manager 5.1.7 with the random-effects model.

The *I*^2^statistic was used to reveal the heterogeneity of treatment effects. *I*^2^of 0 to 40% indicates unimportant heterogeneity, 30 to 60% indicates moderate heterogeneity, 50 to 90% indicates substantial heterogeneity, and 75 to 100% indicates considerable heterogeneity \[[@B25]\]. Heterogeneity was further explored by subgroup analyses and meta-regression. Four potential sources of heterogeneity were analyzed: study design (RCT or NPS); catheter type (C/R, M/R, or silver); sample size; and publication year. Meta-regression analysis was conducted by Stata 12.0 (Stata Corporation, College Station, TX, USA) with the random-effects model to assess whether a specific covariate influenced the effect. The data were expressed with 95% CIs. Two-tailed *P \<*0.05 was deemed statistically significant. The publication bias was examined by the funnel plots on Review Manager 5.1.7, and statistically by Egger\'s regression model, calculated by Stata 12.0.

Results
=======

We identified 144 relevant articles from the initial search and 115 were excluded after a preliminary review. The remaining 29 studies were retrieved for detailed assessment. Sixteen retrospective cohort studies and four studies of ventriculoperitoneal shunt were excluded, with five RCTs and four NPSs related to EVD remaining. Further, one RCT was discarded because no infection event was observed in both the intervention and control groups \[[@B11]\]. Excluding the zero-total-event trials from meta-analysis is common practice because they do not contribute to treatment effects analysis \[[@B26]\]. The flow diagram is shown in Figure [1](#F1){ref-type="fig"}. Eight studies were included in the meta-analysis \[[@B6]-[@B10],[@B12],[@B13],[@B27]\]. Their characteristics are presented in Table [1](#T1){ref-type="table"}. Three NPSs prospectively collected the antimicrobial-impregnated catheter data, and selected well-matched historical controls \[[@B8]-[@B10]\]. The sample size ranged from 39 to 1,634. Most studies involved an adult population and used PSA. The quality of RCTs and NPSs were moderately satisfactory.

![**Selection of studies for our meta-analysis**. RCT, randomized controlled trial.](cc12608-1){#F1}

###### 

Characteristics of the studies included in the meta-analysis

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                  Year   Sample   Male (%)   Population   PSA type                         Treatment arms                                                          Duration^a^(days)   Main outcomes                                                                                                                     Definition of infection                             Score^b^
  --------------------------------------- ------ -------- ---------- ------------ -------------------------------- ----------------------------------------------------------------------- ------------------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------- ---------------------
  **Randomized controlled trials**                                                                                                                                                                                                                                                                                                                                                                   

  Zabramski and colleagues \[[@B6]\]      2003   288      48.6       Adult        PAE                              M/R-impregnated catheter; standard catheter                             8.2 vs. 8.5         CSF infection (%); bacterial colonization (%); organism analyses; complications (%)                                               CC (+)                                              Jadad: R2 B2 A0 = 4

  Wong and colleagues \[[@B12]\]          2010   184      59         Adult        Impregnated: PA; standard: PAE   C/R-impregnated catheter; standard catheter                             10 vs. 10           Nosocomial infection (%); CSF infection (%); length of ICU and hospital stay; functional outcome; organism analyses               CC (+) and CWC (+)/CP (+)/CG (+)                    Jadad: R1 B2 A1 = 4

  Pople and colleagues \[[@B13]\]         2012   357      47.6       Adult        PAE                              M/R-impregnated catheter; standard catheter                             9.3 vs. 9.7         Proven CSF infection (%); suspected CSF infection (%); time to infection; bacteria colonization (%); organism analyses            CC (+) and CS (+); CC (+), CS (+), CWC (+); C (+)   Jadad: R2 B2 A1 = 5

  Har Keong and colleagues \[[@B7]\]      2012   325      52.2       Adult        Not used                         Silver-impregnated catheter; standard catheter                          NA                  CSF infection (%); secondary VP shunt (%)                                                                                         CC (+) or (CM (+) and CWC (+))                      Jadad: R2 B2 A1 = 5

  **Nonrandomized prospective studies**                                                                                                                                                                                                                                                                                                                                                              

  Lackner and colleagues \[[@B8]\]        2008   39       30.8       Adult        PA or PAE (optional)             Silver-impregnated catheter; standard catheter                          15.5 vs. 14         Catheter-associated ventriculitis (%); bacterial colonization (%)                                                                 CC (+)                                              NOS: S3C1O3 = 7

  Tamburrini and\                         2008   91       NA         Pediatric    PAE                              C/R-impregnated catheter; standard catheter                             NA                  Positive CSF culture (%); CSF infection (%); ETV success rate (%); organism analyses                                              CC (+)                                              NOS:\
  colleagues \[[@B10]\]                                                                                                                                                                                                                                                                                                                                                                              S3C1O3 = 7

  Muttaiyah and\                          2010   120      45         Adult +\     NA                               C/R-impregnated catheter; standard                                      7 vs. 6.5           EVD-associated ventriculitis (%); positive CSF culture (%); median time to ventriculitis; organism analyses; cost-effectiveness   CC (+) and\                                         NOS: S3C2O3 = 8
  colleagues \[[@B9]\]                                               pediatric                                                                                                                                                                                                                                                                   CWC (+)                                             

  Harrop and colleagues \[[@B26]\]        2010   1,634    NA         Adult        PA                               C/R-impregnated catheter; M/R-impregnated catheter; standard catheter   NA                  Ventriculostomy infection (%); organism analyses                                                                                  CC (+) and CWC (+)                                  NOS: S4C0O2 = 6
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

C, colonization; CC, cerebrospinal fluid culture; CG, cerebrospinal fluid glucose; CM, clinical manifestations; CP, cerebrospinal fluid protein; C/R, clindamycin/rifampin; CS, cerebrospinal fluid stain; CSF, cerebrospinal fluid; CWC, cerebrospinal fluid white cell count; EVD, external ventricular drainage; ETV, endoscopic third ventriculostomy; M/R, minocycline/rifampin; NA, not available; NPS, nonrandomized prospective studies; PA, perioperative antibiotics; PAE, prolonged antibiotic exposure; PSA, prophylactic systemic antibiotic; RCT, randomized controlled trial; VP, ventriculoperitoneal shunt. ^a^Impregnated catheter versus standard catheter. ^b^Jadad score for RCTs: randomization (R0-2), blinding (B0-2), attrition information (A0-1), total (0-5). Newcastle-Ottawa Quality Assessment Scale (NOS) for cohort studies: selection (S0-4), comparability (C0-2), outcome (O0-3), total (0-9).

Infection rate
--------------

All studies reported the overall rate of CFI in each arm. Accordingly, the OR of the CFI rate could be obtained. Although the definition of infection outcomes varied across studies (Table [1](#T1){ref-type="table"}), they were in accordance with our predefined criteria. As a considerable number of patients underwent EVD several times, we considered the CFI rate to be EVD-frequency related. We thus counted 1,875 EVD events with antimicrobial-impregnated catheters and 1,116 control EVD events with standard catheters. The overall rates of CFIs were 3.6% in patients with antimicrobial-impregnated catheters and 13.7% in patients with standard catheters. The pooled data demonstrated that antimicrobial-impregnated catheters were significantly superior to standard catheters in lowering the CFI rate (OR = 0.25, 95% CI = 0.12 to 0.52, *P \<*0.05; Figure [2](#F2){ref-type="fig"}). As for the Peto OR, the overall difference remained significant (OR = 0.32, 95% CI = 0.24 to 0.42, *P \<*0.05). When sequentially excluding studies from the main pooled analysis, the results were not significantly affected.

![**Effect of antimicrobial-impregnated catheters on cerebrospinal fluid infection**. Pooled odds ratios were calculated using the Mantel-Haenszel (M-H) method with the random-effects model. Results of randomized controlled trials (RCTs) and nonrandomized studies were subanalyzed. CI, confidence interval; NPS, nonrandomized prospective study.](cc12608-2){#F2}

Subgroup analyses were warranted in light of the substantial heterogeneity across studies (*I*^2^= 75%). We analyzed RCTs and NPSs to ascertain the potential bias resulting from study design. Pooled data of four RCTs showed a significant protective effect against CFIs for antimicrobial-impregnated catheters (OR = 0.49, 95% CI = 0.27 to 0.89, *P \<*0.05, *I*^2^= 46%). A significant result was also demonstrated in analysis of four NPSs (OR = 0.12, 95% CI = 0.07 to 0.21, *P \<*0.01, *I*^2^= 0) (Figure [2](#F2){ref-type="fig"}).

Of the eight studies, one RCT and one NPS assessed the effect of silver-impregnated catheters on CFI prevention. As shown in Figure [3](#F3){ref-type="fig"}, less patients with silver-impregnated catheters developed CFIs (10.8%) compared with standard catheters (21.9%), without statistical significance (OR = 0.33, 95% CI = 0.07 to 1.69, *P =*0.18). Harrop and colleagues prospectively utilized C/R and M/R catheters in different observational periods and thus they were pooled separately \[[@B27]\]. Overall, five studies examined the effect of C/R-impregnated catheters and showed a significant association with a lower rate of CFIs (OR = 0.27, 95% CI = 0.10 to 0.73, *P \<*0.05). Two studies evaluated the effect of M/R-impregnated catheters, indicating a significant correlation with a lower rate of CFIs (OR = 0.11, 95% CI = 0.06 to 0.21; *P \<*0.05) (Figure [3](#F3){ref-type="fig"}). When sensitivity analyses were performed with Peto ORs, the only significant change was found for silver-impregnated catheters (Peto OR = 0.45, 95% CI = 0.25 to 0.81, *P \<*0.05).

![**Effect of different antimicrobial-impregnated catheters on cerebrospinal fluid infection**. Pooled odds ratios were calculated using the Mantel-Haenszel (M-H) method with the random-effects model. The effects of three types of antimicrobial-impregnated catheters were explored respectively. CI, confidence interval.](cc12608-3){#F3}

To examine the extent to which differences in the infection rate could be explained, the study design, publication year, and sample size were considered as independent variables in meta-regression analyses. A significant independent effect for study design was indicated (*P =*0.018). However, neither the publication year nor the sample size had an independent effect on the CFI outcome (*P =*0.103 and *P =*0.399, respectively) (Figure [4](#F4){ref-type="fig"}).

![**Meta-regression of the log odds ratio for cerebrospinal fluid infection rate against the sample size**. Size of circle is proportional in area to the study\'s weight in the analysis. *P =*0.399. CSF, cerebrospinal fluid.](cc12608-4){#F4}

Estimation of the time-dependent infection rate
-----------------------------------------------

The EVD catheter was usually temporarily implanted for a short period. Theoretically, all EVD catheters may become infected given enough time. In consideration of the time to infection or censoring, a time-dependent infection rate was explored. Four RCTs illustrated a Kaplan-Meier curve that demonstrated EVD without infection \[[@B6],[@B7],[@B12],[@B13]\]. The infection rate reached a steady level after day 20 following catheter implantation in all studies, and thus the 20-day infection rate was investigated. Three studies presented the *P*value of the log-rank test \[[@B6],[@B12],[@B13]\], whereas the SILVER trial solely presented the Kaplan-Meier curve \[[@B7]\]. The estimated log HR and the standard error of log HR were indirectly calculated, and the pooled results demonstrated that antimicrobial-impregnated catheters were helpful for prolonging the EVD catheter period without infection (HR = 0.52, 95% CI = 0.29 to 0.95, *P*= 0.03) (Figure [5](#F5){ref-type="fig"}).

![**Effect of antimicrobial-impregnated catheters on catheter bacterial colonization**. Pooled hazard ratios were estimated using the inverse variance method, with the random-effects model. CI, confidence interval; SE, standard error.](cc12608-5){#F5}

Catheter bacterial colonization
-------------------------------

Three studies of C/R catheters reported catheter bacterial colonization \[[@B6],[@B12],[@B13]\]. Totally, there were 24 events of bacterial colonization (6.2%) in 389 antimicrobial-impregnated catheters and 48 events of bacterial colonization (12.5%) in 384 standard catheters. The pooled results showed that antimicrobial-impregnated catheters were associated with lower risk of catheter bacterial colonization (OR = 0.37, 95% CI = 0.21 to 0.64, *P \<*0.05) (Figure [6](#F6){ref-type="fig"}).

![**Effect of antimicrobial-impregnated catheters on catheter colonization**. Pooled odds ratios were calculated using the Mantel-Haenszel (M-H) method with the random-effects model. CI, confidence interval.](cc12608-6){#F6}

Microbial spectrum analyses
---------------------------

The specific microbial spectra in CFIs were investigated in five studies (Figure [7](#F7){ref-type="fig"}). For coagulase-negative *Staphylococcus*, antimicrobial-impregnated catheters were superior to standard catheters in lowering the infection rate (OR = 0.17, 95% CI = 0.06 to 0.53, *P \<*0.05). For *Staphylococcus aureus*, a trend but no statistical significance to the decrement of infection rate was shown for the antimicrobial-impregnated catheter group (OR = 0.41, 95% CI = 0.07 to 2.33, *P*\>0.05). Similarly, for Gram negative rods there was a trend of decreasing infection rate in the antimicrobial-impregnated catheter group compared with the standard catheter group without statistical significance (OR = 0.44, 95% CI = 0.07 to 2.58, *P*\>0.05). When analyzing Gram-positive cocci, antimicrobial-impregnated catheters were associated with a lower rate of CFI (OR = 0.18, 95% CI = 0.08 to 0.39, *P \<*0.05). Sensitivity analysis was performed by calculating the Peto OR and no significant change was found.

![**Effect of antimicrobial-impregnated catheters on the prevention of different bacteria spectrum infections**. Pooled odds ratios were calculated using the Mantel-Haenszel (M-H) method, with the random-effects model. CI, confidence interval.](cc12608-7){#F7}

Only few studies were available for resistant organisms, which mainly included drug-resistant *S. aureus*, *Acinetobacter*, *Pseudomonas*, and fungus. Zabramski and colleagues isolated rifampin-resistant *Pseudomonas*species \[[@B6]\]. Wong and colleagues detected one case with methicillin resistant *S. aureus*infection. They also investigated the resistant organisms in the overall nosocomial infections. Resistant infections occurred in 27/90 patients in the antimicrobial-impregnated catheter group and in 34/94 patients in the control group, with no significant difference \[[@B12]\]. Methicillin-resistant *S. aureus*was also reported in the silver-impregnated catheter group in the SILVER trial \[[@B7]\].

Evaluation for publication bias
-------------------------------

The funnel plots of all data were found to be symmetrical, suggesting a low likelihood of publication bias (Figure [8](#F8){ref-type="fig"}). No publication bias was found by Egger\'s test either (*P*= 0.178).

![**Funnel plot showing a small possibility of publication bias**. NPS, nonrandomized prospective study; OR, odds ratio; RCT, randomized controlled trial; SE, standard error.](cc12608-8){#F8}

Discussion
==========

In our meta-analysis, the pooled Mantel-Haenszel OR demonstrated that antimicrobial-impregnated catheters were associated with a decreased rate of CFIs, which was not significantly altered with the Peto OR. A lower rate of catheter bacterial colonization was also indicated in patients with antimicrobial-impregnated catheters. Furthermore, the pooled HR of the 20-day infection rate indicated that patients with antimicrobial-impregnated catheters had a significantly decreased risk of CFI compared with those with standard catheters. Our research suggested a protective effect associated with the use of antimicrobial-impregnated catheters for CFI prevention.

In meta-regression analyses, neither the publication year nor the sample size had a significant effect on the outcome, whereas the study design was shown to exert an independent effect. Further, in subgroup analyses, although results stratified by study design were statistically significant, a significant subgroup difference was found. Considering that the NPSs contributed 75% of patients to the meta-analysis, most of the observed signals may be related to NPSs and not to RCTs. Antibiotic-coated catheters were shown to be effective. However, for the silver-coated catheter, our data did not demonstrate benefit. Compared with antibiotic agents, sliver is expected to exhibit a more widespread antibiotic spectrum, defending against all Gram-positive and Gram-negative bacteria and *Candida*spp. Nevertheless, previous clinical experience of the silver central venous line catheter demonstrated that it is inferior to antibiotic-impregnated catheters for preventing central venous line infection \[[@B28]\]. The comparison of the silver-impregnated catheter with antibiotic-impregnated catheters therefore calls for further investigation.

CFIs often result from contamination along the tract with normal skin flora, such as *Staphylococcus*spp. and *Streptococcus*spp. \[[@B29]\]. Gram-positive cocci comprise the majority of isolates in EVD procedures \[[@B30]\]. Coagulase-negative Staphylococci, predominantly *Staphylococcus epidermidis*, have been identified as the most frequent causative agent of CFIs \[[@B31]\]. Our results demonstrated that antimicrobial-impregnated catheters might reduce the infection risk of Gram-positive cocci, especially *S. aureus*. Nevertheless, no statistically favorable results showed their effects on reducing infection with *S. epidermidis*or Gram-negative rods. Of note, the reason might be that the sample sizes were overall too small to produce conclusive results.

Our meta-analysis is different from previous reviews in several aspects. In the earlier Cochrane review, only two RCTs were included without sufficient data to elucidate the efficacy of antimicrobial-impregnated catheters \[[@B32]\]. In another systematic review, Sonabend and colleagues investigated both the effects of prophylactic antibiotics and antibiotic-coated EVD catheters on ventriculostomy-related infections, and only one RCT of EVD was selected \[[@B2]\]. For another meta-analysis by Thomas and colleagues, the major limitation is the inclusion of considerable low-quality retrospective studies, and mixed assessment of shunt and EVD. Besides, the neonatal population was mainly evaluated \[[@B33]\]. Compared with previous studies, our research consisted of all up-to-date prospective studies of relatively high quality and employed the Mantel-Haenszel OR and the Peto OR to estimate the time-dependent infection rate. Additionally, the benefits of antimicrobial EVD catheters against different microbial spectrums, as well as the efficacy of different catheters, were explored.

We are aware of the limitations for our meta-analysis. One limitation was the quality of studies. Although evidence from RCTs was ideal, only a few RCTs were eligible. Eventually, we identified four RCTs and four NPSs. In three NPSs, historical control groups were employed, which might lead to a failure to identify infections in this group, thus contributing to an underestimated infection rate \[[@B8]-[@B10]\]. Although selection bias has been suggested to be reduced by well-matched historical controls \[[@B8]-[@B10],[@B34]\], its potential existence should not be neglected. The heterogeneity was found to be moderate to considerable, which might arise from the varied infection definition, inappropriate study design with multiple confounding factors, and too small a sample size. Kubilay and colleagues suggested that the implementation of a ventriculostomy placement bundle, including antimicrobial-impregnated catheters, administration of PSA and a series of sterile techniques, dramatically decreased EVD-related infections \[[@B3]\]. The nonstandard surgical procedures between studies therefore probably served as a potential source of heterogeneity. The underlying diseases and severity of conditions also play roles in determining the infectious outcomes, beyond the impregnated antimicrobial agents. It is implied that the efficacy of antimicrobial EVD catheters might be most pronounced in patients with elevated intracranial pressure etiologies of higher infection risk (head trauma, prior shunt failure) \[[@B13]\]. However, the indication of antimicrobial-impregnated catheters for specific populations still remains to be clarified. Especially, the potential confounders are difficult to balance in NPSs. The rate of CFIs is rather low. It has been suggested that 688 procedures are required to detect a decrease in shunt infection rate from 10% to 5% and that 438 procedures are required to detect a decrease in EVD infection rate from 15% to 7.5% \[[@B35]\]. In fact, it is difficult to obtain a sample size large enough for statistical power to find the differences. Antibiotic impregnation may increase false-negative cultures, because whether an inhibitor was used to negate the carryover effect of the antimicrobial agent into the culture medium is not often recorded \[[@B12]\]. Moreover, the reports of time-dependent data were insufficient. We could only estimate the HR of overall infection rate indirectly from information of Kaplan-Meier curves.

The administration of PSA varied between studies, with one study administering perioperative antibiotics \[[@B27]\], three studies employing prolonged antibiotics until the removal of catheters \[[@B6],[@B10],[@B13]\], one study not using any systemic antibiotics \[[@B7]\], and three studies lacking uniform administration or reporting no data \[[@B8],[@B9],[@B12]\] (Table [1](#T1){ref-type="table"}). The PSA usage may thus constitute a source of heterogeneity. Additionally, the controversial interaction between antimicrobial-impregnated catheters and PSA deserves further evaluation. Which is preferable in decreasing CFI, PSA or antimicrobial-impregnated catheters? Are the infection risks of PSA higher than catheter-impregnated antibiotics? Do combined interventions of catheter-impregnated and systemic antibiotics favor the prevention of infection? Current findings may be a dilution of the true individual effect of antimicrobial agent impregnation in the absence of any prophylactic antibiotic therapy.

Another concern is the varied criteria for diagnosing CFIs. In comparison with the Centers for Disease Control guideline, our definition of CFI demonstrated a broader profile with fewer requirements of clinical manifestations. Three studies (3/8) briefly considered positive CSF culture as infection \[[@B6],[@B8],[@B10]\]. Four studies (4/8) enacted more strict criteria, requiring other abnormalities in addition to positive CSF culture, such as elevated CSF white cell counts, elevated CSF protein, or clinical manifestations \[[@B9],[@B12],[@B27]\]. In the absence of positive CSF cultures, we regarded elevated CSF white cell counts with clinical symptoms as evidence of infections \[[@B7]\]. Pople and colleagues have categorized infection outcomes into three classifications: proven infection, suspected infection, and colonization infection \[[@B13]\]. The various definitions not only contribute the heterogeneity, but also increase the complexity of accurately defining EVD infections. In fact, a group of five-grade criteria to describe CSF infections in ventriculostomy has been proposed, which included contamination, ventriculostomy colonization, suspected ventriculostomy-related infection, ventriculostomy-related infection, and ventriculitis \[[@B30]\]. Notwithstanding the difficulties in stratifying infection events, the specified classification might be helpful for future studies as demonstrated by Pople and colleagues\' trial \[[@B13]\].

Conclusion
==========

Our results demonstrate that antimicrobial-impregnated catheters are effective and safe in lowering the risk of CFIs and catheter colonization and are helpful in improving EVD catheter use without infection. Especially, the antimicrobial-impregnated catheters play roles against Gram-positive organisms. Antibiotic-impregnated catheters appear to be reliable options for patients requiring EVD placements. However, no sufficient evidence supports the use of silver-impregnated catheters. Further well-designed studies are needed to verify the findings of our meta-analysis.
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